tradingkey.logo

LENSAR Inc

LNSR
View Detailed Chart
12.045USD
+0.035+0.29%
Market hours ETQuotes delayed by 15 min
143.76MMarket Cap
LossP/E TTM

LENSAR Inc

12.045
+0.035+0.29%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.29%

5 Days

+4.65%

1 Month

+22.53%

6 Months

-2.94%

Year to Date

+34.73%

1 Year

+56.43%

View Detailed Chart

TradingKey Stock Score of LENSAR Inc

Currency: USD Updated: 2025-12-19

Key Insights

LENSAR Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 104/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 15.00.In the medium term, the stock price is expected to remain stable.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

LENSAR Inc's Score

Industry at a Glance

Industry Ranking
104 / 208
Overall Ranking
236 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Hold
Current Rating
15.000
Target Price
+34.05%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

LENSAR Inc Highlights

StrengthsRisks
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 51.29% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 53.49M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 53.49M.
Fairly Valued
The company’s latest PE is -2.75, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.64M shares, decreasing 1.71% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 507.60K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.07.

LENSAR Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

LENSAR Inc Info

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
Ticker SymbolLNSR
CompanyLENSAR Inc
CEOCurtis (Nicholas T)
Websitehttps://www.lensar.com/

FAQs

What is the current price of LENSAR Inc (LNSR)?

The current price of LENSAR Inc (LNSR) is 12.045.

What is the symbol of LENSAR Inc?

The ticker symbol of LENSAR Inc is LNSR.

What is the 52-week high of LENSAR Inc?

The 52-week high of LENSAR Inc is 17.310.

What is the 52-week low of LENSAR Inc?

The 52-week low of LENSAR Inc is 7.250.

What is the market capitalization of LENSAR Inc?

The market capitalization of LENSAR Inc is 143.76M.

What is the net income of LENSAR Inc?

The net income of LENSAR Inc is -31.40M.

Is LENSAR Inc (LNSR) currently rated as Buy, Hold, or Sell?

According to analysts, LENSAR Inc (LNSR) has an overall rating of Hold, with a price target of 15.000.

What is the Earnings Per Share (EPS TTM) of LENSAR Inc (LNSR)?

The Earnings Per Share (EPS TTM) of LENSAR Inc (LNSR) is -4.374.
KeyAI